A detailed history of Brinker Capital Investments, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 48,517 shares of ZLAB stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,517
Previous 48,433 0.17%
Holding current value
$1.06 Million
Previous $1.69 Million 2.89%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$28.4 - $40.51 $2,385 - $3,402
84 Added 0.17%
48,517 $1.64 Million
Q2 2025

Aug 14, 2025

BUY
$24.32 - $43.03 $296,071 - $523,847
12,174 Added 33.58%
48,433 $1.69 Million
Q1 2025

Jul 31, 2025

BUY
$24.29 - $38.35 $590,319 - $932,020
24,303 Added 203.27%
36,259 $1.31 Million
Q4 2024

Jul 31, 2025

BUY
$24.61 - $33.18 $294,237 - $396,700
11,956 New
11,956 $313,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.13B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.